Studying middle-aged populations is important to understanding what Alzheimer’s disease looks like in the earliest stages, to ...

A newly identified enzyme called IDOL could become a major new target in the fight against Alzheimer’s disease. Researchers ...

Millions of people are diagnosed with Alzheimer's disease each year, comprising 60% to 70% of dementia cases worldwide. While cognitive impairment and structural brain changes are indicative of ...

The Alzheimer's risk gene APOE ε4 drives the aggressive, brain-wide Type 2 subtype of ALS, causing cognitive decline.

A new study suggests the APOE2 longevity gene may protect the brain from Alzheimer's by helping neurons repair DNA damage and ...

A recently-used statistical approach may overstate links between amyloid reduction and cognitive outcomes, a study suggested. The technique, known as quantile aggregation, groups data into quantiles, ...

Founded in 2018 by Kerrin Laz, proprietor of K. Laz Wine Collection, the annual fundraising event has now generated more than $11 million to support Alzheimer’s research, care and advocacy efforts.

Conventional wisdom suggests that voter angst over healthcare affordability will haunt the party in power this November. But ...

Christopher Lock, MD, spoke with Healio about findings from the Evoke and Evoke+ trials presented at the 2026 American ...

Passage of the Alzheimer’s Screening and Prevention Act is one of several practical steps available to reduce rural health ...

Japanese medical startup Sound Wave Innovation, which aims to cure Alzheimer’s disease with ultrasound therapy, has raised ...